Safety and Efficacy Study of APD125 in Patient With Insomnia

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274

NCT02852395 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model

NCT03284931 ·Status: COMPLETED ·Phase: PHASE1

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

NCT00420810 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression

NCT00518986 ·Status: COMPLETED ·Phase: PHASE4

Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag Disorder

NCT00758498 ·Status: COMPLETED ·Phase: PHASE3

A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia

NCT00569972 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

NCT00683436 ·Status: TERMINATED ·Phase: PHASE2

An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia

NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3

Clinical Study to Assess a Dietary Supplement on Sleep Health and Quality

NCT05368909 ·Status: COMPLETED ·Phase: NA

Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory Performance

NCT00711516 ·Status: COMPLETED ·Phase: PHASE4

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

NCT00247390 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ABT-652 in Subjects With Excessive Daytime Sleepiness

NCT01124851 ·Status: COMPLETED ·Phase: PHASE1

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

NCT02671760 ·Status: COMPLETED ·Phase: PHASE2

Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

NCT01092845 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder

NCT02841709 ·Status: COMPLETED ·Phase: PHASE2

Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)

NCT00078325 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

NCT00228566 ·Status: COMPLETED ·Phase: PHASE3

A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary Insomnia

NCT00551148 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

NCT00095069 ·Status: COMPLETED ·Phase: PHASE3

A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

NCT01002625 ·Status: TERMINATED ·Phase: PHASE1

Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs

NCT03312517 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy

NCT00078377 ·Status: COMPLETED ·Phase: PHASE3

A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)

NCT00770692 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

NCT02464046 ·Status: COMPLETED ·Phase: PHASE2

Comparison of IN 10 003 to Placebo in Subjects With Insomnia Suffering From Difficulty in Falling Asleep and Staying Asleep

NCT01196650 ·Status: COMPLETED ·Phase: PHASE2